Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.

BACKGROUND Scatter factor/hepatocyte growth factor (SF/HGF) is a pleiotropic growth factor that stimulates proliferation and migration of endothelial cells (ECs) via the c-Met receptor, present on ECs as well as other cell types, including smooth muscle cells (SMCs). We studied the effects of recombinant human (rh) SF/HGF in vitro and in vivo in a rabbit model of hindlimb ischemia. We further compared these effects with those of recombinant human vascular endothelial growth factor (rhVEGF165), an EC-specific mitogen. METHODS AND RESULTS In vitro, rhSF/HGF and rhVEGF165 exhibited similar effects on proliferation and migration of ECs. When both cytokines were administered together, the result was an additive effect on EC proliferation and a synergistic effect on EC migration. Application of rhSF/HGF to cultures of human SMCs resulted in the induction of VEGF mRNA and protein. In vivo, administration of rhSF/HGF (500 microg x 3) was associated with significant improvements in collateral formation (P<.001) and regional blood flow (P<.0005) and with a significant reduction in muscle atrophy (P<.0001). These effects were significantly more pronounced than those of rhVEGF165 administered according to the same protocol (P<.05). Neither remote angiogenesis nor other pathological sequelae were observed with either rhSF/HGF or rhVEGF165. CONCLUSIONS The pleiotropic effects of certain growth factors may potentiate angiogenesis via a combination of direct effects on EC proliferation and migration and indirect effects that result in the generation of other potent EC mitogens from non-EC populations. The synergistic effects demonstrated when SF/HGF and VEGF are administered together in vitro may be reproduced in vivo by SF/HGF-induced upregulation of VEGF in vascular SMCs.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Isner,et al.  Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA. , 1997, Cardiovascular research.

[3]  A. Matsumori,et al.  Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. , 1997, Circulation.

[4]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[5]  Takayuki Asahara,et al.  Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.

[6]  B. Keyt,et al.  VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. , 1996, The Journal of surgical research.

[7]  Peipei Ping,et al.  Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart , 1996, Nature Medicine.

[8]  M. Aoki,et al.  Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. , 1996, Biochemical and biophysical research communications.

[9]  B. Keyt,et al.  The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[10]  B. Keyt,et al.  Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. , 1996, The Journal of clinical investigation.

[11]  G. Camussi,et al.  In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Aoki,et al.  Expression of local hepatocyte growth factor system in vascular tissues. , 1995, Biochemical and biophysical research communications.

[13]  J. Pearlman,et al.  Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis , 1995, Nature Medicine.

[14]  R. Schwall,et al.  Sulfated Oligosaccharides Promote Hepatocyte Growth Factor Association and Govern Its Mitogenic Activity (*) , 1995, The Journal of Biological Chemistry.

[15]  R. Schwall,et al.  Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor. , 1995, The American journal of physiology.

[16]  J. Isner,et al.  Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. , 1995, Journal of vascular surgery.

[17]  J. Isner,et al.  Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. , 1994, The American journal of physiology.

[18]  W Grossman,et al.  Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. , 1994, The Journal of clinical investigation.

[19]  Atsushi Namiki,et al.  Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only , 1994 .

[20]  S. Epstein,et al.  Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. , 1994, Circulation.

[21]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[22]  P. Godowski,et al.  In vivo response of hepatocytes to growth factors requires an initial priming stimulus , 1994, Hepatology.

[23]  K. Kurokawa,et al.  Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats , 1993, Hepatology.

[24]  C. Birchmeier,et al.  Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development , 1993, The Journal of cell biology.

[25]  G. Matejka,et al.  Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle. , 1993, American Journal of Physiology.

[26]  W. Birchmeier,et al.  The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells , 1993, The Journal of cell biology.

[27]  H. Kleinman,et al.  Scatter factor induces blood vessel formation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Kohno,et al.  Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. , 1993, Experimental cell research.

[29]  L. Orci,et al.  Biphasic Effect of Transforming Growth Factor-β1 on in Vitro Angiogenesis , 1993 .

[30]  J. Isner,et al.  Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology. , 1992, Journal of the American College of Cardiology.

[31]  L. Naldini,et al.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth , 1992, The Journal of cell biology.

[32]  K. Miyazawa,et al.  Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. , 1992, The Journal of biological chemistry.

[33]  H. M. Payne,et al.  Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.

[34]  M. Kuwano,et al.  Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture. , 1991, Biochemical and biophysical research communications.

[35]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[36]  E. Gherardi,et al.  Hepatocyte growth factor--scatter factor: mitogen, motogen, and met. , 1991, Cancer cells.

[37]  G. Heusch,et al.  Measurement of Regional Myocardial Blood Flow With Multiple Colored Microspheres* , 1991, Circulation.

[38]  M. V. Doyle,et al.  Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[40]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[41]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[42]  A. Ziada,et al.  The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. , 1984, Cardiovascular research.

[43]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[44]  W. Falk,et al.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. , 1980, Journal of immunological methods.

[45]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[46]  E. Brogi,et al.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. , 1994, Circulation.

[47]  Sandra R. Smith,et al.  Growth factor effects on cells of the vascular wall: a survey. , 1993, Growth factors.

[48]  J. Winer,et al.  Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. , 1991, Methods in enzymology.